Morgan Stanley’s PepGen PEPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.9K Sell
48,842
-950,145
-95% -$1.54M ﹤0.01% 6314
2026
Q1
$1.77M Sell
998,987
-85,413
-8% -$480K ﹤0.01% 4844
2025
Q4
$7.06M Buy
1,084,400
+509,244
+89% +$2.64M ﹤0.01% 3915
2025
Q3
$2.66M Buy
575,156
+510,318
+787% +$823K ﹤0.01% 4604
2025
Q2
$72K Buy
64,838
+32
+0% +$45 ﹤0.01% 6238
2025
Q1
$91.1K Sell
64,806
-488,672
-88% -$1.01M ﹤0.01% 6056
2024
Q4
$2.1M Buy
553,478
+494,622
+840% +$3.08M ﹤0.01% 4665
2024
Q3
$503K Buy
58,856
+31,830
+118% +$377K ﹤0.01% 5401
2024
Q2
$431K Sell
27,026
-1,456
-5% -$20.9K ﹤0.01% 5359
2024
Q1
$419K Sell
28,482
-7,435
-21% -$87.8K ﹤0.01% 5393
2023
Q4
$244K Buy
35,917
+25,985
+262% +$143K ﹤0.01% 5622
2023
Q3
$50.5K Sell
9,932
-4,664
-32% -$29.7K ﹤0.01% 6166
2023
Q2
$130K Buy
14,596
+1,534
+12% +$20.1K ﹤0.01% 5827
2023
Q1
$160K Buy
13,062
+6,893
+112% +$108K ﹤0.01% 5808
2022
Q4
$82.5K Buy
6,169
+4,863
+372% +$62.8K ﹤0.01% 6071
2022
Q3
$12K Buy
1,306
+48
+4% +$472 ﹤0.01% 7014
2022
Q2
$13K Buy
+1,258
New +$14K ﹤0.01% 7140

Other funds holding PEPG

Morgan Stanley's PEPG Position: Q2 2026 in Review

Morgan Stanley reduced its PepGen (PEPG) stake by 95% in Q2 2026, selling an estimated $1.54M and leaving 48,842 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6314.

Morgan Stanley first reported a position in PEPG in Q2 2022 and has held it in 17 quarters since. The position peaked at $7.06M in Q4 2025. 71 funds tracked by Wall St. Rank hold PEPG as of Q2 2026.

  • Morgan Stanley held 48,842 shares of PepGen worth $87.9K as of Q2 2026.
  • Morgan Stanley sold 950,145 PepGen shares in Q2 2026, an estimated $1.54M.
  • PepGen made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6314 holding.
  • Morgan Stanley first reported a position in PepGen in Q2 2022 and has held it in 17 quarters since.
  • Morgan Stanley's PepGen position peaked at $7.06M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held PepGen as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.